CN Patent

CN116783164A — 制备柠檬酸阿瑞洛莫及其中间体的方法

Assigned to Zevela Denmark GmbH · Expires 2023-09-19 · 3y expired

What this patent protects

本公开涉及一种制备阿瑞洛莫、柠檬酸阿瑞洛莫及其关键中间体如ORZY‑01的方法。本公开还涉及制备高纯度柠檬酸阿瑞洛莫的方法及其使用方法。

USPTO Abstract

本公开涉及一种制备阿瑞洛莫、柠檬酸阿瑞洛莫及其关键中间体如ORZY‑01的方法。本公开还涉及制备高纯度柠檬酸阿瑞洛莫的方法及其使用方法。

Drugs covered by this patent

arimoclomol-citrate (ARIMOCLOMOL CITRATE)

Patent Metadata

Patent number: CN116783164A
Jurisdiction: CN
Classification: —
Expires: 2023-09-19
Drug substance claim: No
Drug product claim: No
Assignee: Zevela Denmark GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.